.webp&w=384&q=75){kind=logo}
Loading, please wait...
Loading, please wait...
The FDA recently highlighted a significant Boston Scientific heart recall affecting various cardiac devices. This regulatory action follows reports of several deaths and thousands of serious injuries. Therefore, clinicians must stay informed about the required corrections. However, the FDA does not recommend removing the devices from patients. Instead, doctors should update the software during scheduled clinic visits. Consequently, this measure aims to mitigate risks without invasive surgery.
The affected hardware includes the Accolade, Essentio, and Proponent models, among others. Specifically, these pacemakers and cardiac resynchronization therapy devices require the Brady SMR6 software patch. Boston Scientific developed this patch to fix issues stemming from a previous software version. Furthermore, the agency is monitoring additional updates regarding a potential battery drain issue. Thus, timely intervention is essential for patient safety.
Doctors must prioritize patients who are at higher risk. For instance, individuals with low battery life or those who rely entirely on the device need immediate follow-up. In addition, routine monitoring remains standard for other patients. Because the recall is Class I, the risks of inaction are severe. Consequently, medical teams should coordinate these updates promptly. This proactive approach ensures that the devices function correctly and prevent future complications.
Q1: Do these devices need to be surgically removed?
No, the FDA does not recommend device explant. Instead, a software update during an in-person clinic visit is sufficient to address the issue.
Q2: Which models are affected by this recall?
The recall involves the Accolade, Essentio, Proponent, Altrua 2, Valitude, and Visionist pacemakers and CRT devices.
Q3: What is the risk if the software is not updated?
Failure to update the software can lead to serious injury or death, as the correction fixes critical logic errors.
Disclaimer: This content is for informational and educational purposes only. It does not constitute medical advice or replace professional judgment. Refer to the latest local and national guidelines for clinical practice.
References
Read summarized clinical updates, watch expert medical content, and earn CME certifications right from your smartphone.
Open your smartphone camera to scan and install.
Boston Scientific issues a Class I recall for pacemakers like Accolade and Proponent. Software updates are required to address serious safety issues and dea...
4 months ago
A new study reveals that lipid-related metabolic dysregulation, marked by elevated TG/HDL-C ratio and glymphatic changes, independently impacts survival in idiopathic normal pressure hydrocephalus.
Today
A premature neonate developed upper limb compartment syndrome after uterine rupture extruded the arm through a scar defect. Conservative management with continuous monitoring yielded complete functional recovery and normal limb growth at 10-year follow-up, highlighting non-operative safety in selected cases.
Today
A meta-analysis of 13 propensity score-matched studies shows ViV-TAVR delivers lower early mortality and reduced bleeding compared to redo-SAVR for degenerated bioprosthetic aortic valves, though long-term hemodynamics warrant careful anatomical and patient-centered evaluation.
Today
Endoscopic posterior cervical fusion combines minimally invasive decompression, joint preparation, and rigid screw-rod fixation for atlantoaxial pathologies. Early clinical findings demonstrate solid bony union, excellent symptom relief, and minimal soft-tissue morbidity without significant vascular compromise.
Yesterday
The All-India Food Processors' Association has approached the Supreme Court to oppose FSSAI's proposed per-100g benchmark for front-of-pack warning labels, advocating instead for a per-serving threshold. We explore the regulatory showdown, nutritional evidence, and implications for clinical lifestyle counseling.
Today
